TSS:Rfhg 179813.1

Basic information about the TSS

---

TSS ID: rfhg_179813.1 TSS ID(Version3): hg_152211.1 Species: human Chr: chr16		Start: 2205710 End: 2205811 Strand: +
Source datasets	FANTOM5|DRA013844|PRJNA615891|PRJNA401781|PRJNA4843412
Protocol	CAGE|SLIC_CAGE|NETCAGE
TSS cluster detected*	5

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2836940,EH38E1796474)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000566835.5:0 ENST00000397124.5:0 ENST00000565250.1:0 AK022227:0 GeneID: 64223 HGNC/MGI_ID: HGNC:24825 UniProt_ID: H3BPT1 Q9BVC4 Nearer transcript ids and distances: ENST00000301724.14:-216 BC020499:-216 ENST00000563067.5:218 BC017119:218 ENST00000565717.5:-220 ENST00000567282.5:-223 BC001313:-223 ENST00000564679.5:-226 ENST00000561651.5:-229 ENST00000565687.5:-229 ENST00000566653.5:-233 ENST00000568194.5:-239 BC052292:-239 BC088354:-243 ENST00000563107.5:-245 ENST00000565269.1:-253 ENST00000567928.5:-254 ENST00000562479.5:-254 ENST00000562844.5:-254 ENST00000562851.5:-256 ENST00000567623.6:-256 ENST00000562352.5:-256 ENST00000565330.5:-256 ENST00000569417.6:-256 NM_001199173.3:-256 NM_001352060.2:-256 NM_001199175.3:-256 NM_022372.6:-256 NM_001352057.2:-256 NM_001352059.2:-256 NM_001199174.3:-256 NR_147904.2:-256 NR_147906.2:-256 NR_147905.2:-256 NR_147907.2:-256 AK302201:-256 ENST00000564294.5:-260 AK304390:-260 LF210723:-262 MA446300:-262 DQ894803:263 EU176591:263 DQ891611:263 CU677841:274 AY223837:-287 ENST00000568542.5:-453 AK098762:-468 ENST00000570224.5:-485 view more...

Gene_name: MLST8 Gene_symbol: MLST8 Gene_synonyms: GBL GbetaL Lst8 Pop3 Gene_source: HGNC:24825

TATA-Box annotation

---

Distance to TSS:	306
Nearest PromoterID:	NM_001352060
Entrez ID:	64223
Nearest Unigene:	Hs.29203
Nearest Refseq:	NM_022372
Nearest Ensembl:	ENSG00000167965
Gene Name:	MLST8
Gene Alias:	GBL|GbetaL|LST8|POP3|WAT1
Gene Type:	protein-coding
CpG%:	0.138614
GC%:	0.803922
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MLST8 p2@MLST8 p3@MLST8 p4@MLST8 p5@MLST8 p6@MLST8
Sample		p1@MLST8	p2@MLST8	p3@MLST8	p4@MLST8	p5@MLST8	p6@MLST8
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.21	16.75	7.01	1.17	6.62	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	40.46	21.04	3.64	1.42	6.47	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	40.90	19.10	6.75	1.74	5.21	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.85	17.46	4.16	1.46	5.41	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	31.27	15.75	6.52	1.57	6.75	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	42.25	14.73	5.04	0.78	7.56	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	53.82	22.22	6.32	3.49	9.15	1.53
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	51.11	19.14	5.09	3.15	12.35	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	53.86	27.36	9.83	3.21	11.75	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	60.28	38.26	9.27	4.64	18.55	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	64.27	38.81	5.66	6.47	15.77	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	60.58	37.00	4.47	4.47	25.61	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.50	21.28	8.87	1.45	0.48	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	34.28	16.54	7.07	0.75	0.15	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	34.03	20.42	6.81	1.32	0.88	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.69	20.87	5.78	1.51	0.00	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	33.20	22.50	6.33	1.97	0.22	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.54	21.51	8.44	0.84	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	29.32	11.73	6.40	1.60	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	39.72	18.96	6.62	0.60	1.20	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	31.54	21.65	6.95	2.14	0.53	2.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.39	13.98	6.04	0.86	0.00	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	30.50	15.77	4.78	0.52	0.26	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.30	15.77	6.79	0.73	0.49	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	33.54	19.35	4.90	0.77	0.52	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	41.15	17.09	9.18	1.27	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.37	10.99	4.95	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	35.83	17.21	5.42	1.18	0.94	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	33.76	19.87	5.17	1.62	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.67	14.66	4.34	0.36	0.54	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.54	18.00	6.49	0.42	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	34.00	14.46	5.08	0.78	0.78	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	33.34	18.99	6.12	1.48	0.42	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.50	8.25	7.09	1.65	0.66	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.53	15.15	4.49	1.87	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	30.47	14.95	4.41	1.72	0.00	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	33.31	15.74	3.88	0.61	0.00	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.43	14.51	4.63	1.41	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	34.57	15.13	4.86	1.89	1.08	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.93	14.16	5.04	1.92	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	30.82	15.76	4.00	1.41	0.24	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.43	8.64	2.93	1.61	0.44	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	35.43	15.40	4.64	0.84	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.44	17.48	3.85	1.75	0.17	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.34	14.46	4.42	1.00	0.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	34.20	17.45	2.09	0.93	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	31.43	16.31	2.40	1.68	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.08	16.99	2.09	0.89	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.55	14.84	2.39	1.44	1.68	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	36.60	13.55	2.22	1.82	0.81	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.92	12.71	1.84	1.02	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.14	14.68	2.22	0.67	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	27.32	14.55	0.71	1.06	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	26.18	11.27	3.98	1.33	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	7.55	1.68	1.68	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	28.01	5.05	3.67	1.84	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	31.11	11.34	1.94	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	24.73	13.81	0.64	0.64	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	26.09	5.66	2.20	0.94	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	22.56	13.40	0.71	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	23.55	10.65	1.12	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.90	2.39	0.00	6.37	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.37	4.42	1.02	3.06	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	21.12	10.40	1.62	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.04	8.16	1.77	1.77	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.21	6.34	0.49	1.46	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	16.86	9.42	0.50	0.50	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	6.57	0.00	0.47	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.54	4.31	0.66	1.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	17.94	10.21	0.62	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	21.40	11.31	1.22	0.61	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	19.16	12.51	1.43	0.48	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	19.41	15.40	0.96	1.12	0.96	0.32
Adipocyte - omental, donor1	11473-119C6	17.18	9.80	1.15	0.64	0.64	0.25
Adipocyte - omental, donor2	11474-119C7	20.18	8.97	1.49	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	20.76	15.41	0.67	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	22.97	14.04	2.55	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	29.69	4.40	0.00	1.10	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	19.87	19.87	4.52	0.45	0.00	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	21.90	33.54	1.56	0.70	0.52	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	18.19	20.93	0.59	0.39	0.20	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	12.61	20.33	1.54	0.51	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	20.91	27.04	3.35	1.39	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	19.40	2.94	2.35	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	22.52	14.00	1.29	3.38	0.72	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	14.85	18.72	2.26	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	15.46	1.07	1.60	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	11.13	1.67	1.67	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	25.37	17.88	0.42	1.25	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	18.59	13.56	1.00	1.76	1.26	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	17.67	15.71	0.33	0.98	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	24.36	9.74	1.52	2.13	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	28.51	31.60	2.87	1.99	1.77	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	65.62	43.75	6.10	2.87	3.94	2.15
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	28.75	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	39.04	7.20	2.70	0.54	0.90	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	56.90	8.37	5.02	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	33.08	11.09	2.47	0.41	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	27.00	11.10	3.32	0.34	0.69	0.69
Anulus Pulposus Cell, donor2	11463-119B5	35.27	12.49	1.22	0.49	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.32	13.48	2.25	0.90	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	24.31	7.38	2.60	1.30	0.43	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	8.56	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.03	3.59	1.20	0.00	0.30	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	30.35	5.06	1.26	0.00	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	25.08	10.56	1.98	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	24.04	9.75	1.62	0.00	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.24	7.28	3.40	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.88	7.13	2.38	1.19	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.94	7.16	2.26	1.51	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.14	9.43	3.63	1.45	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	13.79	1.25	0.00	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	25.20	9.72	2.97	0.66	0.33	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	6.82	5.46	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	24.88	7.54	1.96	0.30	0.45	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.25	8.04	0.54	0.54	1.07	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.41	8.31	1.70	0.76	0.19	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.98	8.82	2.67	0.53	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	11.71	0.00	1.95	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	23.05	7.46	3.32	1.49	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	7.20	1.20	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.73	10.29	3.43	1.37	1.03	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	31.07	3.88	5.34	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.01	7.97	3.79	1.90	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	4.85	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.94	8.55	0.57	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.88	8.76	2.57	0.64	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	21.42	8.52	2.58	1.55	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	25.81	8.45	3.28	2.82	0.00	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.08	9.32	1.61	0.96	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.12	8.56	1.43	1.43	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	9.94	4.09	1.17	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.29	12.04	1.20	0.60	0.60	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	10.69	1.19	2.38	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	22.38	13.73	2.54	0.51	1.53	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.38	8.40	4.58	0.51	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	27.96	8.90	5.08	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	24.60	4.75	3.45	0.00	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	19.90	7.83	2.12	0.64	0.42	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	21.75	8.41	1.74	0.29	0.00	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	3.78	3.78	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	24.24	9.32	2.88	0.85	1.36	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	6.34	6.34	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	22.73	8.58	3.00	1.29	0.64	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	4.21	1.80	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	25.51	5.83	0.00	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	27.36	8.74	2.76	0.92	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.85	6.61	1.78	1.02	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	23.95	9.29	1.45	0.83	1.45	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.83	11.93	2.75	1.22	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.60	6.21	0.96	1.91	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.61	9.09	2.22	1.11	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	15.26	1.53	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.69	7.75	2.22	0.55	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.15	7.41	2.12	1.32	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.44	9.09	2.18	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	59.20	25.91	7.12	0.49	1.35	1.23
Astrocyte - cerebellum, donor2	11580-120F5	63.50	26.53	7.19	0.86	1.88	1.20
Astrocyte - cerebellum, donor3	11661-122F5	35.66	24.96	8.60	1.05	1.47	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	33.12	20.92	1.74	0.35	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	36.40	25.07	0.81	0.49	0.49	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	36.10	27.74	2.09	1.34	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	28.56	14.22	9.75	1.03	0.80	1.95
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.44	16.16	8.77	1.38	0.88	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	25.95	13.88	6.15	0.80	0.91	0.80
Basophils, donor1	12241-129G9	12.03	1.31	0.00	0.52	0.00	0.00
Basophils, donor2	12242-129H1	23.09	2.16	0.72	0.36	0.00	0.00
Basophils, donor3	12243-129H2	21.61	4.41	0.29	0.15	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	23.72	28.89	1.94	0.00	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	74.06	36.57	5.03	0.46	0.91	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	59.63	40.80	8.79	1.88	3.77	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	71.95	55.52	4.78	2.29	1.66	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	34.54	31.55	3.68	0.00	0.69	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	19.43	22.49	2.34	0.36	0.90	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	40.50	21.33	3.09	0.00	0.62	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	32.84	27.25	4.66	1.63	0.47	1.63
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	34.54	15.67	3.20	2.56	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	31.03	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	18.60	4.51	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	16.52	4.08	0.00	0.19	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	16.25	2.63	0.66	0.00	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	16.42	15.85	1.42	0.00	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	24.26	15.92	2.27	1.52	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	21.70	17.09	0.66	0.99	0.66	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	10.55	2.17	0.14	0.14	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	9.96	3.32	0.30	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	12.79	1.90	0.00	0.24	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.87	1.00	0.17	0.17	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.21	2.48	0.28	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	10.91	3.22	0.00	0.50	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.27	1.37	0.00	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.70	3.56	0.18	0.18	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	8.05	1.74	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.38	1.64	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.73	2.11	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	3.33	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	10.41	1.64	0.00	0.45	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.38	2.20	0.40	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.03	0.83	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.26	1.83	0.46	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.98	2.71	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.86	0.87	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.61	1.88	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.37	3.14	0.17	0.00	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	12.20	2.95	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	1.47	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	0.00	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	0.00	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.32	1.22	0.00	0.00	0.35	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.81	2.23	0.37	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.93	1.51	0.22	0.22	1.29	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.32	0.82	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.49	1.16	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.64	0.23	0.00	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	22.23	3.92	0.22	0.87	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	28.41	2.08	0.69	0.23	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	21.23	3.68	0.87	0.65	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	30.37	7.94	0.31	0.47	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	28.64	3.32	0.52	0.17	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	23.86	8.70	0.22	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	22.46	2.81	0.26	0.51	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	24.15	1.10	0.00	0.66	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	23.37	1.47	0.21	0.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	0.00	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	19.66	6.10	3.39	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	29.00	5.18	1.04	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	29.85	3.20	3.73	3.20	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	4.29	1.07	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	19.65	3.51	2.81	2.11	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	25.10	7.06	2.35	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	19.77	3.95	7.91	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	40.27	0.82	1.64	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	43.53	2.90	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	32.31	4.04	2.02	0.50	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	48.49	10.91	1.21	0.81	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	49.94	6.79	0.00	0.40	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	20.08	6.02	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	20.23	3.93	1.12	0.56	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	36.82	17.28	1.88	3.76	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	37.88	13.75	1.35	2.25	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	27.85	2.14	1.43	0.36	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	36.74	4.29	2.45	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	33.55	6.40	3.35	0.00	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	25.01	6.13	8.93	0.26	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.73	7.19	7.64	0.22	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	32.77	8.05	9.20	0.00	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	37.45	5.22	6.64	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	42.14	3.51	3.51	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	6.59	16.48	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.85	5.93	2.89	0.29	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	26.27	4.07	4.24	1.02	0.51	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.44	5.32	4.51	0.64	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.41	3.14	2.24	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	28.30	1.40	1.75	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	26.84	0.88	5.28	0.00	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	36.26	5.48	3.79	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.93	6.03	3.32	0.62	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	36.75	6.68	3.34	0.33	1.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	40.52	5.44	4.62	0.00	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	40.73	2.68	5.36	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	44.83	3.59	0.00	0.00	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	29.85	5.38	4.26	0.37	0.74	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.08	4.77	4.33	0.65	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	28.58	7.57	5.04	0.84	1.47	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	31.35	2.02	4.55	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	28.16	3.47	2.17	0.00	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	28.33	2.61	4.79	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	35.14	5.94	6.43	0.49	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	35.08	5.54	5.54	0.00	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	6.98	6.98	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	53.72	7.75	12.18	1.11	1.38	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	50.80	2.94	10.80	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	24.64	7.70	3.08	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	28.29	6.80	4.66	0.72	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	38.78	4.15	5.54	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	24.55	3.27	2.29	0.00	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	21.40	3.38	3.38	0.38	1.13	0.00
CD8+ T Cells, donor3	11383-118B6	33.33	3.79	1.51	0.00	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	38.54	22.48	3.67	3.44	0.69	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	40.50	24.92	3.59	4.31	2.16	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.74	19.15	5.20	3.83	1.64	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	44.13	5.70	4.20	5.10	1.50	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	41.76	28.56	4.56	3.60	1.92	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.52	24.33	4.55	3.41	1.82	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.90	18.90	1.52	5.43	1.96	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.32	23.43	1.84	4.74	1.58	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	30.96	22.98	3.05	4.22	1.64	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.32	22.04	3.62	4.53	1.81	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	33.12	22.37	2.61	2.32	1.45	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.97	19.72	5.60	4.53	2.13	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.51	15.32	1.31	3.06	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	30.97	9.56	1.82	1.37	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	11.19	2.24	3.73	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	37.10	22.69	3.60	5.40	2.16	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	38.55	29.06	1.15	3.45	1.15	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	35.83	24.04	4.24	4.24	1.41	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.32	22.18	3.49	3.49	1.58	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	35.06	20.30	2.15	5.54	1.54	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	27.89	22.76	3.53	2.89	1.92	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	33.66	21.42	4.21	4.59	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	34.29	21.28	5.52	5.12	2.76	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.21	22.69	3.78	6.05	1.51	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	26.50	14.45	1.61	0.80	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.77	14.69	4.20	2.10	2.10	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	44.08	17.03	4.01	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	5.48	1.83	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	20.75	9.39	1.48	1.48	1.98	0.49
Cardiac Myocyte, donor3	11686-122I3	20.42	13.58	3.26	0.42	1.26	0.42
Chondrocyte - de diff, donor1	11261-116G1	41.25	16.64	4.85	0.69	0.69	1.04
Chondrocyte - de diff, donor2	11338-117F6	18.83	12.79	2.13	0.36	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	20.14	11.95	2.16	0.57	0.11	0.46
Chondrocyte - re diff, donor2	11339-117F7	31.33	18.80	3.58	1.79	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	12.54	21.03	2.43	0.40	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	33.97	18.02	2.98	0.57	0.92	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	28.43	14.75	2.57	1.28	0.21	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	30.89	18.32	2.30	0.80	0.80	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	51.63	15.13	5.04	0.83	2.02	0.64
Corneal Epithelial Cells, donor1	11526-119I5	36.67	35.57	4.17	0.22	0.66	1.10
Corneal Epithelial Cells, donor2	11606-120I4	36.40	15.93	2.28	1.14	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	34.77	31.70	3.07	0.26	0.77	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.86	8.09	0.33	0.33	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	14.19	6.94	0.63	0.32	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	16.41	6.70	0.43	0.32	0.43	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.91	1.71	0.00	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	20.89	0.65	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	22.75	0.97	0.48	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	30.19	18.51	2.00	2.33	0.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	19.36	19.95	2.93	0.59	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	31.96	14.99	2.55	2.55	1.70	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	27.13	21.23	2.75	1.18	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	27.05	15.71	1.16	1.45	0.58	0.87
Endothelial Cells - Artery, donor2	11341-117F9	34.82	24.47	2.35	3.53	1.18	1.41
Endothelial Cells - Artery, donor3	11413-118E9	42.07	19.46	1.75	2.98	1.40	0.88
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.07	15.29	0.66	1.11	1.11	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.82	14.30	2.74	2.13	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.10	13.25	1.13	1.69	0.85	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	38.03	7.73	0.89	2.38	0.59	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	24.47	11.98	2.08	1.56	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	27.36	9.22	0.28	1.56	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	38.01	17.61	6.00	2.80	2.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	21.49	12.58	1.05	1.05	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.58	20.13	1.12	2.98	0.99	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	24.12	21.73	0.22	2.39	0.65	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.04	21.25	1.22	3.66	0.85	0.12
Endothelial Cells - Vein, donor1	11267-116G7	40.95	26.16	1.14	1.14	3.41	1.14
Endothelial Cells - Vein, donor2	11344-117G3	32.83	25.84	5.59	3.49	2.10	1.40
Endothelial Cells - Vein, donor3	11416-118F3	28.89	22.77	0.94	2.67	1.26	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	34.94	28.59	2.20	0.49	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	58.24	33.28	2.08	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.99	11.49	1.23	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.59	10.29	3.18	0.44	0.77	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.18	21.78	6.61	0.98	1.52	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.62	9.94	2.43	0.73	0.73	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	15.01	4.09	4.64	1.36	0.55	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.71	11.92	4.85	0.42	0.63	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.02	3.69	6.59	0.53	0.53	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	23.92	12.96	4.32	2.66	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	29.94	14.97	6.35	1.36	1.36	0.00
Fibroblast - Cardiac, donor2	11345-117G4	28.80	14.40	1.52	0.76	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	34.86	19.87	3.63	0.95	0.32	0.79
Fibroblast - Cardiac, donor4	11452-119A3	27.58	15.46	4.55	0.61	0.61	1.21
Fibroblast - Cardiac, donor5	11456-119A7	24.11	15.10	1.90	0.63	0.38	0.38
Fibroblast - Cardiac, donor6	11460-119B2	34.41	11.67	1.36	0.76	0.91	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.57	11.93	5.63	0.67	1.47	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.43	11.22	2.16	0.43	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	21.97	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	68.73	34.83	6.92	3.00	1.38	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	29.68	14.76	2.04	0.17	0.68	0.51
Fibroblast - Dermal, donor1	11269-116G9	18.78	24.89	3.76	0.47	0.23	2.82
Fibroblast - Dermal, donor2	11346-117G5	43.39	37.73	8.02	1.42	1.89	3.77
Fibroblast - Dermal, donor3	11418-118F5	25.02	20.91	3.14	0.24	0.48	1.21
Fibroblast - Dermal, donor4	11450-119A1	35.16	28.49	3.84	0.90	1.13	0.79
Fibroblast - Dermal, donor5	11454-119A5	34.89	22.33	2.44	0.35	1.92	0.70
Fibroblast - Dermal, donor6	11458-119A9	40.28	20.95	2.27	0.65	1.62	1.14
Fibroblast - Gingival, donor1	11237-116D4	21.86	11.66	3.12	0.62	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	25.94	8.12	1.83	1.83	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	24.78	17.13	2.64	1.05	1.45	0.40
Fibroblast - Gingival, donor3	11394-118C8	32.00	21.46	4.54	0.19	0.58	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	15.58	17.66	5.19	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.51	10.92	1.41	0.53	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.61	9.98	1.71	1.71	0.94	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.99	8.52	2.43	1.22	0.54	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.47	7.06	0.71	2.82	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.93	14.62	1.32	0.73	1.90	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	29.32	8.86	1.91	0.55	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	35.54	9.10	1.10	2.30	1.65	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.93	9.83	1.61	1.03	0.15	0.29
Fibroblast - Lung, donor1	11270-116H1	25.83	24.47	2.72	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	13.43	2.98	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	41.57	23.64	4.43	1.27	1.06	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	49.98	19.99	5.83	1.67	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	39.16	18.18	4.20	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	36.38	15.11	1.12	2.52	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	49.93	31.67	2.84	0.81	4.06	1.62
Fibroblast - Mammary, donor2	11620-122A9	55.92	35.95	3.99	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	17.87	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.16	19.59	1.55	1.94	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	36.86	26.39	1.67	0.61	0.61	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	25.40	12.24	3.06	2.45	1.22	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.13	9.16	0.00	1.53	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	20.79	8.64	2.16	0.27	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.83	14.50	1.51	1.04	0.35	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.34	10.94	1.55	1.55	0.77	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	48.77	12.39	2.24	2.44	2.03	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	33.41	17.37	4.68	1.34	2.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	31.23	13.84	7.12	0.40	0.79	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.60	4.37	0.99	1.39	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.16	11.01	1.78	0.18	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.77	12.22	3.15	0.39	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.68	5.42	4.21	1.20	0.90	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	23.75	10.36	2.81	0.11	0.43	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	21.51	2.53	2.53	0.51	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	16.90	11.65	1.97	0.49	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.87	3.81	2.81	0.80	0.40	1.60
Fibroblast - skin normal, donor2	11561-120D4	24.51	13.76	2.81	0.80	1.11	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	22.67	5.44	1.51	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	19.80	14.17	1.41	0.08	0.17	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	25.47	14.53	1.88	0.00	0.34	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.06	2.30	1.64	0.66	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	26.63	9.91	1.81	0.85	0.32	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	30.53	9.61	1.69	0.51	0.67	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.13	2.82	2.35	0.31	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	22.16	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.99	6.97	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.38	12.66	1.73	1.56	1.04	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.09	10.67	1.56	0.52	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.97	8.18	2.81	0.77	1.28	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	55.12	60.48	0.77	0.77	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	59.98	61.89	3.83	1.91	3.19	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	52.20	59.05	0.86	1.71	2.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	71.15	55.98	1.93	0.00	1.93	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.89	29.23	1.37	0.68	0.91	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	47.95	69.74	0.59	0.79	2.18	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	61.06	49.96	1.59	0.26	2.64	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	39.79	36.85	1.63	0.33	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	45.99	59.26	0.88	2.21	4.42	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	38.16	41.83	2.40	0.42	2.12	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.17	39.16	4.19	1.23	1.35	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	42.71	45.67	1.88	2.15	1.88	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.92	38.65	1.61	0.74	0.74	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.95	32.39	1.11	0.42	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.91	29.48	1.22	0.41	1.42	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.64	44.72	5.25	0.68	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.67	35.63	1.87	0.75	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	21.64	41.31	1.31	0.87	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	34.57	49.94	4.73	1.18	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	28.14	41.49	3.97	0.95	1.11	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	31.50	46.92	4.24	0.45	0.67	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	30.25	40.13	2.82	1.81	0.40	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	28.33	28.16	6.62	1.02	0.34	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	26.34	37.06	3.19	1.33	0.53	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.03	58.90	6.76	0.83	0.62	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.96	49.35	8.03	1.54	0.68	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.98	36.29	3.98	0.33	0.77	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.46	34.19	4.41	0.75	0.58	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.64	29.61	5.92	1.02	1.43	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	33.22	35.07	4.75	0.41	1.03	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.17	36.09	5.88	0.35	0.46	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.35	36.19	3.17	1.33	0.50	1.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	27.99	38.35	4.41	0.00	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	33.08	39.73	7.75	0.61	0.12	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.23	29.50	4.05	0.97	0.81	2.43
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.00	47.79	5.77	0.64	0.32	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	28.99	31.46	5.31	0.76	0.66	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	24.68	35.27	4.11	0.63	0.32	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.98	36.49	4.26	0.91	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	24.04	24.04	5.33	1.25	0.52	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	26.13	31.40	6.37	1.10	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.09	31.14	4.21	0.56	1.12	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.94	21.30	3.70	1.39	0.65	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.59	22.46	5.88	0.80	1.87	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.03	24.63	5.05	1.68	0.46	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.96	23.32	2.98	2.46	1.42	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.02	26.02	4.07	1.08	0.00	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	23.04	27.84	4.24	0.92	0.92	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.05	26.54	4.17	0.66	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	41.65	28.76	5.95	0.00	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.05	23.74	2.24	0.40	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	24.82	20.38	2.42	0.61	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.43	38.38	4.07	0.25	0.51	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	47.18	48.37	1.59	1.59	1.39	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.22	57.93	3.08	0.15	1.54	2.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	48.28	58.31	0.41	1.02	1.84	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	46.63	61.96	1.88	2.19	3.13	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	51.43	60.47	3.39	0.85	4.24	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	41.97	39.66	2.77	0.46	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	44.55	4.95	2.47	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	43.32	47.19	2.71	0.77	2.32	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	51.34	8.02	0.00	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	46.95	43.47	10.43	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	38.08	40.36	2.93	1.63	2.28	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.77	37.89	2.47	1.65	2.47	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	63.31	33.32	0.00	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.07	37.19	2.80	0.00	1.96	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	39.55	46.41	1.63	1.31	2.94	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	44.46	37.75	4.19	0.84	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	33.40	45.48	2.54	0.00	1.59	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.42	43.82	2.38	0.34	1.36	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	48.03	58.47	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.82	45.24	1.72	1.15	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.07	40.25	3.26	1.18	2.07	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	40.66	20.33	6.78	3.39	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	49.29	28.58	3.31	0.41	2.49	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	50.86	30.38	1.61	2.07	4.14	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	31.61	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	37.67	26.91	1.92	0.38	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.40	25.10	2.61	0.65	1.96	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	32.77	40.13	4.68	0.67	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	37.37	48.93	1.54	0.39	1.16	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	46.90	32.86	2.40	0.34	1.71	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	54.67	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	53.79	48.13	2.83	0.00	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.38	42.24	1.81	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	45.27	40.19	4.07	1.02	1.53	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	39.49	44.67	1.99	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	35.03	37.99	3.95	0.00	1.97	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	30.69	20.07	0.00	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.09	39.09	3.50	0.00	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	30.28	50.47	5.71	0.00	0.44	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	25.43	39.84	2.54	0.00	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	23.28	0.60	0.60	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	34.45	17.95	0.49	0.97	2.43	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	20.54	13.70	1.14	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	26.61	7.90	4.16	0.00	0.83	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	51.72	12.37	0.00	1.12	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	20.30	7.29	1.59	0.00	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.55	7.52	0.42	0.42	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	33.54	16.36	4.76	5.92	3.71	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	31.90	17.05	4.73	2.87	2.87	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	28.44	20.93	2.96	2.73	3.19	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	31.59	16.40	5.57	5.57	1.97	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.74	15.90	4.08	5.37	3.44	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.20	20.02	5.38	2.37	3.23	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	32.38	21.17	4.73	5.98	1.49	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.88	19.21	2.40	5.15	3.26	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.00	16.34	1.60	5.13	2.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	48.13	15.67	3.92	1.68	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	37.22	22.51	1.73	0.87	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	15.86	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	37.04	13.76	3.17	0.71	1.41	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	33.42	20.34	6.54	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.45	11.89	2.27	1.05	1.22	0.17
Hepatocyte, donor1	11523-119I2	20.58	12.11	0.00	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	23.70	8.62	0.00	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	15.95	7.36	0.00	1.84	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.95	15.66	6.53	0.65	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.64	21.32	3.32	1.05	1.22	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.72	12.90	1.23	0.96	0.55	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	105.07	66.86	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	66.75	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	92.75	38.76	6.92	4.15	2.77	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	87.59	35.04	5.01	2.50	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	30.75	17.94	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	82.27	41.14	13.71	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	103.96	35.74	8.12	1.62	3.25	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	95.04	31.68	8.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	87.13	29.04	0.00	0.00	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	82.06	52.94	7.94	3.97	0.00	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	74.28	42.13	7.76	5.54	3.33	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	47.14	5.24	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	79.36	27.08	2.52	1.26	0.63	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	116.00	37.12	6.19	3.09	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	102.44	14.63	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	83.98	30.36	5.81	1.29	1.94	3.23
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	94.99	33.81	9.66	9.66	3.22	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	23.90	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	97.79	32.60	4.07	1.63	0.81	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	90.26	36.94	5.46	2.52	1.68	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	43.12	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	88.41	35.36	8.04	4.02	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	82.17	27.70	3.69	0.92	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	30.16	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	66.09	25.96	4.25	1.89	2.36	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	78.91	34.47	6.35	0.91	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	44.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	72.10	35.51	6.46	2.15	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	78.77	45.74	11.43	1.27	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	32.86	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	67.59	21.04	7.65	1.28	2.55	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	100.25	41.92	9.11	5.47	5.47	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	84.26	39.27	4.28	2.86	1.43	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	46.46	13.27	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	53.71	29.01	8.03	2.16	0.62	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	89.56	43.90	8.78	1.76	1.76	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	59.72	40.86	18.86	6.29	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	70.93	29.21	11.13	0.70	3.48	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	81.88	55.33	6.64	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	119.95	68.08	9.73	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	107.25	48.83	6.98	3.49	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	105.74	42.75	6.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	62.72	6.97	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	115.21	43.74	12.80	0.00	3.20	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	108.06	44.33	13.85	0.00	1.39	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	71.24	45.59	11.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	80.08	46.02	6.44	2.76	1.84	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	99.84	54.46	6.05	3.03	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	161.43	49.67	6.21	0.00	0.00	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	94.11	35.95	5.29	1.06	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	18.28	16.48	1.63	0.16	1.14	0.16
Keratinocyte - epidermal, donor2	11349-117G8	38.07	31.04	8.78	0.59	2.34	1.17
Keratinocyte - epidermal, donor3	11421-118F8	22.62	23.85	2.27	0.47	0.85	0.57
Keratinocyte - oral, donor1	11251-116E9	29.17	28.49	3.52	0.45	0.79	0.45
Keratocytes, donor1	11527-119I6	49.17	30.60	5.85	3.09	1.03	1.38
Keratocytes, donor2	11607-120I5	49.22	9.37	1.17	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	20.55	20.35	2.17	0.40	0.59	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	32.97	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	19.42	12.94	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	34.48	28.72	6.34	0.92	0.69	1.61
Lens Epithelial Cells, donor3	11690-122I7	22.60	13.72	4.24	0.81	0.30	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	22.06	10.20	2.61	2.13	0.95	1.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.61	6.98	1.12	1.95	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	18.89	5.82	0.94	1.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	26.35	7.53	1.61	3.23	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	24.90	10.40	0.95	1.89	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	19.73	9.70	0.54	2.16	0.22	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.93	5.75	1.64	2.05	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.63	9.86	1.01	2.28	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.68	6.76	0.70	2.39	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.80	7.12	1.98	0.79	0.00	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	21.33	6.79	0.78	1.36	0.58	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	24.62	7.78	0.93	2.04	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	22.65	6.27	2.44	1.05	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.43	8.35	1.43	1.43	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.82	8.65	0.82	2.47	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	17.55	6.16	0.62	1.54	0.31	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	28.99	7.79	1.25	2.18	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.41	9.70	1.65	2.93	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	24.03	8.23	0.99	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.92	9.37	2.05	2.64	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	30.37	8.96	0.75	1.49	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	8.73	1.45	0.00	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.70	6.46	1.35	1.35	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.25	6.96	0.91	1.67	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.00	6.74	2.07	2.59	0.00	2.07
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	25.55	4.61	0.63	1.26	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.65	7.97	0.60	1.95	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	16.51	7.57	2.06	1.38	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	22.95	5.46	1.32	1.32	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	22.16	7.32	0.95	1.59	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.93	6.78	1.94	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	19.52	5.29	0.99	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.32	7.56	0.74	2.11	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.58	8.51	0.74	2.96	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.78	4.45	2.47	0.49	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.21	8.11	1.37	1.79	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.47	7.40	1.93	2.25	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.96	6.39	1.22	0.61	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.44	6.16	1.54	2.10	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.87	7.11	2.13	2.13	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	28.12	6.30	2.42	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	25.83	8.09	0.78	3.27	0.47	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.13	6.80	2.15	2.15	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.21	7.19	2.61	0.33	0.65	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	22.84	5.41	1.41	3.30	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.81	11.39	2.60	2.97	0.25	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.59	7.17	1.79	2.82	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.90	6.56	0.90	1.49	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	36.26	13.60	4.53	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	40.66	1.53	3.07	6.14	2.30	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	40.82	3.71	3.71	8.91	4.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	50.78	4.65	4.23	3.81	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	73.15	9.14	2.11	3.52	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	48.57	2.80	2.80	5.60	4.67	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	46.37	3.61	2.06	5.15	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	45.20	4.76	4.76	8.33	3.57	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	48.18	5.20	4.75	4.98	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	37.81	2.91	2.91	3.78	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	41.87	4.50	1.80	3.15	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	56.63	5.55	4.74	5.42	2.03	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	39.03	3.59	4.11	3.08	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.17	7.41	1.76	4.59	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	43.98	2.00	2.00	3.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	61.13	7.13	5.09	4.58	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	45.09	5.07	3.47	3.74	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	44.78	4.35	2.08	5.10	2.46	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	49.70	5.52	6.14	8.59	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	52.19	8.15	1.63	5.71	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	45.40	4.79	1.25	3.12	1.87	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.15	3.36	1.68	3.08	1.96	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	48.43	2.06	7.21	4.12	5.15	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	37.45	2.61	3.48	4.94	2.61	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	46.63	5.38	2.39	3.29	2.39	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	40.94	7.19	0.55	6.64	2.77	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	51.61	6.01	4.24	6.36	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	50.15	6.27	4.43	4.43	2.58	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	48.35	3.45	4.61	4.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	53.73	5.37	2.69	3.45	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	49.82	3.96	9.06	3.96	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	50.87	6.56	4.10	1.64	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	45.64	4.52	5.42	3.16	4.97	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.75	4.31	3.59	2.87	5.03	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	51.54	2.99	1.49	4.48	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	41.99	5.20	4.09	5.20	3.34	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.86	3.45	4.74	3.45	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	43.67	3.43	1.71	5.14	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	49.31	5.33	4.33	4.66	3.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	50.68	6.64	6.03	7.24	1.21	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	45.50	5.69	2.13	3.55	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	46.40	6.87	5.50	3.78	1.37	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	34.89	5.37	3.22	3.76	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	51.85	8.75	2.02	3.37	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	45.93	5.19	2.96	6.30	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	1.16	2.33	3.49	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	38.08	4.23	3.17	5.29	6.35	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	42.82	5.60	5.60	3.20	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	62.51	4.36	4.36	3.63	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	72.82	3.07	6.13	5.37	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	55.25	7.89	2.96	5.43	1.97	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	40.46	7.53	10.35	3.76	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	64.36	8.55	4.53	7.04	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	54.07	7.66	2.70	4.06	3.15	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	39.59	5.16	1.72	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	67.69	5.79	4.45	4.90	2.67	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	58.26	5.47	3.13	5.87	2.74	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	36.29	4.62	4.62	3.30	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	60.20	4.15	4.15	7.26	2.59	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	42.01	4.38	3.50	7.00	2.19	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	32.99	1.68	3.35	3.35	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	51.23	5.74	3.53	7.51	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	51.69	2.70	5.01	6.94	1.93	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	37.98	2.03	2.03	4.56	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	38.93	7.21	1.92	4.33	2.40	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	43.33	3.18	1.99	8.75	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.28	4.86	5.47	4.25	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	50.49	3.46	4.15	2.77	3.46	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	54.34	5.32	2.66	5.32	2.28	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	48.03	4.65	5.16	3.10	2.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	47.77	3.02	4.23	4.84	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	45.00	3.80	3.49	4.44	1.90	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	43.71	3.73	6.40	4.26	2.67	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	59.77	5.17	5.17	2.30	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	45.25	6.17	1.54	4.63	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	34.66	7.07	7.07	4.24	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	64.69	7.94	6.24	3.40	2.84	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	47.43	6.24	5.41	7.49	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	26.62	3.13	3.13	2.35	1.57	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	55.12	2.09	5.43	5.01	2.51	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.72	7.43	6.04	5.11	1.86	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	27.43	6.02	3.35	4.01	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	57.74	3.21	6.95	3.74	2.14	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	44.05	2.83	4.45	6.06	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	29.37	7.34	11.93	7.34	4.59	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	35.56	5.33	6.22	4.45	5.33	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	35.33	5.13	5.13	4.56	2.85	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	36.81	3.07	6.90	8.44	1.53	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	44.32	6.57	8.21	3.28	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	38.75	4.45	4.90	5.79	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.35	5.72	6.24	6.76	1.04	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	40.45	4.64	9.95	6.63	1.99	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	8.31	22.86	2.08	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	14.36	9.12	1.82	0.46	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	23.12	8.99	0.92	0.18	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	20.97	12.58	1.18	1.84	0.52	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.46	7.43	1.59	0.00	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	13.47	7.29	1.27	0.79	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	20.01	7.64	1.25	1.39	1.53	0.14
Mammary Epithelial Cell, donor1	11273-116H4	33.78	13.65	4.38	1.59	0.80	0.20
Mammary Epithelial Cell, donor2	11350-117G9	25.77	17.37	3.76	1.16	0.87	0.87
Mammary Epithelial Cell, donor3	11422-118F9	41.90	19.70	1.00	0.75	1.50	0.50
Mast cell - stimulated, donor1	11487-119E2	12.20	0.68	1.36	5.42	0.68	0.00
Mast cell, donor1	11563-120D6	26.93	6.70	2.38	5.19	0.87	0.43
Mast cell, donor2	11565-120D8	18.42	2.08	0.00	0.30	0.59	0.30
Mast cell, donor3	11566-120D9	15.98	2.25	0.45	1.35	0.23	0.00
Mast cell, donor4	11567-120E1	21.27	1.60	0.18	1.24	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	22.95	6.99	1.89	2.22	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	18.09	2.33	0.58	0.58	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	19.50	5.74	1.72	3.67	0.46	0.11
Mast cell, expanded, donor8	11941-126A6	21.26	7.36	0.84	3.68	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	23.08	13.43	0.60	3.08	0.60	0.10
Melanocyte - dark, donor2	11582-120F7	29.07	16.61	1.38	0.35	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	32.53	33.32	3.26	1.09	0.94	0.94
Melanocyte - light, donor1	11274-116H5	27.97	53.13	4.47	1.65	0.47	1.18
Melanocyte - light, donor2	11351-117H1	50.50	51.18	2.73	2.05	0.00	2.05
Melanocyte - light, donor3	11423-118G1	34.69	35.56	0.87	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	27.49	24.47	5.10	1.56	0.94	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	24.47	20.98	6.72	1.34	0.81	2.42
Melanocyte, donor3 (MC+3)	12837-137B2	25.71	40.18	4.82	0.80	2.41	2.14
Meningeal Cells, donor1	11493-119E8	51.24	16.50	4.84	0.99	1.36	0.25
Meningeal Cells, donor2	11573-120E7	50.62	15.41	7.04	0.88	0.44	1.32
Meningeal Cells, donor3	11654-122E7	26.41	9.86	2.85	0.49	1.06	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	24.24	13.40	3.42	0.57	0.57	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.81	23.55	5.43	1.11	0.60	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	90.68	77.54	9.20	3.94	1.31	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	54.94	24.86	1.31	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	23.68	12.92	1.44	2.15	2.15	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.46	11.01	2.75	0.00	0.64	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	20.11	9.05	1.51	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	36.70	21.10	2.20	0.22	3.74	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	29.95	14.61	1.46	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	32.53	23.53	2.86	1.64	2.46	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.82	13.57	3.19	0.14	0.00	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	44.98	20.44	2.60	2.23	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	22.24	11.32	3.03	0.13	0.66	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.19	16.02	3.26	0.59	0.30	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	30.36	30.36	2.34	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.10	21.77	7.68	0.00	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.20	10.28	2.48	0.71	1.42	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	17.51	14.39	2.81	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	33.38	19.59	3.63	2.18	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	21.48	11.93	2.92	1.59	1.86	0.27
Mesothelial Cells, donor2	12156-128G5	14.51	12.51	2.00	2.00	2.00	0.50
Mesothelial Cells, donor3	11402-118D7	19.22	7.01	1.16	1.37	0.79	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	37.81	25.66	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.16	12.81	1.97	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.08	13.55	1.18	0.88	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	27.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	17.67	9.92	1.24	1.24	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.03	11.62	0.83	1.24	0.62	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	18.53	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	20.52	13.76	2.75	0.25	0.00	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.60	8.84	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.83	11.38	1.22	1.02	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.17	9.90	0.00	0.79	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	8.85	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	24.32	11.02	0.76	0.38	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	5.26	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.22	9.97	0.85	0.85	1.06	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	8.29	14.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.01	9.24	0.89	0.89	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	10.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.06	9.28	0.50	0.75	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.54	10.93	0.71	0.48	0.24	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	6.63	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	20.26	9.21	0.23	0.23	1.15	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.04	7.99	0.00	0.63	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.84	6.11	0.00	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.73	7.29	0.43	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.45	6.45	0.22	0.89	0.89	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.07	6.57	0.22	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	10.14	1.01	0.00	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	4.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.97	7.34	0.27	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.82	10.00	0.59	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	5.45	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	5.29	0.96	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.01	6.80	0.00	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.51	7.01	0.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.70	3.50	0.00	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	8.83	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	11.53	1.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.14	4.71	0.50	0.99	0.74	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	15.31	6.96	0.00	0.70	2.09	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.68	1.71	0.68	0.68	1.37	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	12.69	4.81	0.44	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.72	2.13	0.00	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.15	3.09	0.00	1.40	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	3.33	0.00	1.66	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.82	1.17	0.00	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.57	3.92	0.00	0.60	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	13.36	4.17	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	1.71	0.00	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.13	2.07	0.14	1.38	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	14.25	2.07	0.00	1.04	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.73	1.29	0.00	1.72	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	0.64	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.75	1.33	0.27	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.26	3.29	0.00	0.90	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.57	2.83	0.28	0.99	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	15.29	3.50	0.32	3.82	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.36	1.77	0.00	0.88	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.48	2.65	0.00	1.90	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.65	3.98	0.00	1.42	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	20.40	4.18	0.25	0.25	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.47	3.53	0.29	1.18	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.59	4.61	0.00	0.86	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.13	3.30	0.41	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	5.36	1.19	1.49	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	11.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	12.48	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	32.53	26.29	0.33	0.66	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	28.40	12.62	3.16	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.29	15.62	2.57	0.20	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	33.53	17.70	0.93	0.93	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	29.29	11.27	0.75	1.13	0.75	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	36.22	18.64	1.33	0.00	0.53	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.61	13.23	1.13	1.47	0.68	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.73	19.89	0.74	0.00	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	25.28	27.85	1.47	1.47	0.73	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	17.11	1.56	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.03	3.21	1.60	0.00	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	7.73	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	40.40	21.21	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.35	13.07	0.84	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	7.55	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	0.00	0.00	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	19.60	10.56	2.37	1.51	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	23.52	20.38	10.45	0.00	0.00	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	40.05	3.34	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	23.79	30.47	2.50	1.25	1.25	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	27.76	8.75	5.70	2.66	1.33	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	36.70	57.45	6.38	3.19	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	22.44	3.40	0.68	0.68	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	0.00	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.53	29.72	3.77	0.00	0.42	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	30.91	26.27	6.04	0.23	0.93	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.64	37.56	6.76	0.81	0.27	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	26.70	27.12	5.26	0.21	1.05	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.34	24.32	6.95	0.50	0.50	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.28	16.24	4.60	0.00	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.80	24.03	3.85	0.23	0.45	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.58	30.21	3.27	0.33	0.33	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.50	23.33	7.11	1.82	0.36	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	30.23	16.44	6.90	0.00	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	22.81	3.60	0.00	0.60	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.66	5.25	5.25	0.66	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.59	25.53	3.58	0.49	0.33	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.34	28.57	6.00	0.35	0.18	2.12
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	23.91	2.11	0.70	0.00	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	15.17	24.82	1.38	0.46	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.24	28.28	4.82	0.64	0.32	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.93	3.45	4.14	1.38	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.61	25.40	4.68	0.67	0.22	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.36	22.86	3.39	0.42	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.80	17.80	2.85	0.00	0.71	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.31	29.19	6.01	1.29	1.29	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.33	35.65	7.00	0.00	0.33	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	16.23	32.46	2.25	0.90	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.44	24.20	4.76	0.00	0.40	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	16.72	3.71	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.03	24.97	5.68	0.00	1.14	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.36	26.72	2.61	0.00	0.98	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.33	51.42	5.67	0.00	0.00	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	20.81	31.66	4.52	0.45	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	18.52	4.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	12.63	29.25	1.99	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.81	32.74	5.95	0.00	0.50	3.47
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	37.90	2.30	0.38	1.15	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.61	23.59	6.05	0.60	1.21	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.36	24.09	3.98	1.55	0.22	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.94	33.21	2.03	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	22.56	46.95	8.54	0.61	0.00	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.74	47.84	1.57	0.31	0.31	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	12.41	63.25	4.84	0.30	0.00	2.72
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	19.78	33.23	2.37	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	5.67	2.27	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	5.06	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	14.04	8.70	3.23	1.12	0.37	0.87
Myoblast, donor2	11322-117D8	16.88	18.99	3.45	1.53	0.38	0.38
Myoblast, donor3	11398-118D3	20.18	14.29	4.04	1.18	1.01	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.06	29.33	4.23	0.73	0.44	1.17
Natural Killer Cells, donor1	11230-116C6	22.45	0.62	0.62	0.31	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	25.03	2.11	1.21	0.60	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	25.22	2.21	1.84	0.74	0.37	0.37
Neural stem cells, donor1	11275-116H6	38.83	23.59	3.63	1.45	0.00	0.73
Neural stem cells, donor2	11352-117H2	82.80	13.48	9.63	0.00	1.93	0.00
Neurons, donor1	11494-119E9	44.38	23.90	3.41	2.28	0.00	0.00
Neurons, donor2	11574-120E8	38.75	23.78	7.27	1.10	0.00	0.00
Neurons, donor3	11655-122E8	80.57	18.09	1.64	0.82	3.29	2.47
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.22	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	24.58	11.40	3.56	0.00	0.36	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	25.40	16.61	2.93	0.00	0.00	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	25.87	14.04	6.62	0.40	0.40	2.01
Olfactory epithelial cells, donor1	11933-125I7	28.08	7.02	1.65	0.41	0.69	0.28
Olfactory epithelial cells, donor2	11934-125I8	24.03	6.51	1.88	0.58	0.72	0.58
Olfactory epithelial cells, donor3	11935-125I9	23.72	8.17	2.38	0.11	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	17.04	10.23	3.02	0.58	0.39	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	21.06	15.65	0.60	1.20	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	22.12	34.24	4.04	0.43	0.64	0.85
Osteoblast - differentiated, donor2	11353-117H3	21.72	43.44	10.29	2.29	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	19.86	31.04	4.34	2.48	0.62	3.10
Osteoblast, donor1	11277-116H8	59.80	25.99	7.82	0.78	1.37	1.95
Osteoblast, donor2	11354-117H4	19.66	8.43	2.81	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	31.10	27.19	3.20	0.71	0.71	0.53
Pancreatic stromal cells, donor1	11249-116E7	18.28	9.52	2.53	0.67	0.59	0.59
Pericytes, donor1	11491-119E6	55.19	34.60	17.80	0.56	0.78	2.78
Pericytes, donor2	11571-120E5	51.39	20.83	7.70	0.91	1.13	1.36
Pericytes, donor3	11652-122E5	33.77	17.90	3.26	1.63	0.81	0.41
Perineurial Cells, donor1	11499-119F5	22.38	9.38	2.49	0.23	0.45	0.34
Perineurial Cells, donor2	11579-120F4	26.41	14.08	0.92	0.92	0.37	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	21.36	3.19	0.96	0.32	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	17.63	1.71	0.98	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.91	3.75	1.29	0.13	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	45.20	21.29	2.63	0.24	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	55.44	16.63	8.87	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	50.26	17.28	1.77	0.20	1.57	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	19.94	15.19	0.95	1.27	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	16.51	14.07	2.44	0.75	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.79	3.92	1.04	0.65	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	19.81	15.54	1.58	0.23	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	16.84	15.56	4.16	0.11	0.75	0.53
Preadipocyte - omental, donor2	11329-117E6	19.64	12.22	2.18	0.87	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	20.77	15.04	1.43	1.29	0.57	0.29
Preadipocyte - perirenal, donor1	11469-119C2	24.61	17.72	2.95	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	39.00	38.08	3.38	1.84	0.92	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	26.21	20.01	3.01	0.71	0.89	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	26.73	22.82	1.36	0.51	0.34	0.85
Preadipocyte - visceral, donor1	11280-116I2	25.80	20.03	4.38	0.28	1.40	0.56
Preadipocyte - visceral, donor2	11357-117H7	16.57	10.58	2.76	0.46	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	28.11	15.88	3.45	0.31	0.73	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.21	14.78	3.47	0.30	1.81	0.45
Prostate Epithelial Cells, donor2	11331-117E8	14.76	8.26	1.90	0.54	0.95	0.27
Prostate Epithelial Cells, donor3	11404-118D9	8.27	17.82	4.29	0.31	0.24	0.37
Prostate Stromal Cells, donor1	11254-116F3	16.97	10.02	2.62	2.16	0.80	0.46
Prostate Stromal Cells, donor2	11332-117E9	17.75	8.07	1.08	0.54	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	20.75	10.64	3.02	0.63	0.31	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	40.88	31.39	5.84	2.55	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.61	11.71	1.87	1.18	0.21	0.28
Renal Epithelial Cells, donor1	11517-119H5	72.53	49.71	7.61	4.06	4.06	1.01
Renal Epithelial Cells, donor2	11597-120H4	63.31	27.03	2.13	5.69	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.95	13.23	1.59	0.95	0.53	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	41.53	16.34	3.40	4.09	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	33.56	19.95	2.16	1.62	0.81	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	26.86	13.32	2.44	1.55	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	45.25	22.63	3.33	3.33	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	44.46	17.39	3.96	1.32	1.76	1.76
Renal Mesangial Cells, donor2	11598-120H5	46.40	20.06	1.88	0.63	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	51.04	19.42	4.99	0.55	1.11	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	38.65	23.89	1.34	5.10	1.07	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	37.95	24.04	3.37	2.11	1.27	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	44.74	24.49	2.31	2.12	1.54	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	32.15	24.37	4.67	2.59	0.52	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	44.91	23.31	8.24	1.71	0.57	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	44.25	41.16	4.12	2.06	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	27.60	21.33	4.52	0.50	1.51	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.38	7.08	1.20	1.07	0.40	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	16.97	17.87	8.93	3.57	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	9.91	6.60	12.66	2.20	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	15.66	9.86	8.12	5.22	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	20.93	7.67	3.90	2.60	0.52	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.13	11.22	5.86	3.48	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	19.74	11.71	5.35	2.23	0.11	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	16.13	6.45	4.71	1.98	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	20.28	11.19	5.59	2.68	0.47	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	21.73	14.33	5.32	5.08	0.23	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	18.21	8.63	4.93	2.60	0.68	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.00	9.53	4.99	3.48	1.06	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	16.66	10.57	3.23	3.76	0.54	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.52	7.60	6.74	1.86	1.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	19.10	9.77	3.65	3.33	0.32	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	20.58	10.18	3.32	2.66	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.74	10.13	4.01	2.87	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.70	9.32	4.19	2.61	0.47	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	16.91	13.15	6.20	2.07	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.17	11.81	6.50	3.05	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.19	10.03	3.41	3.60	0.29	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	17.57	11.08	4.96	3.44	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.75	8.12	5.23	2.56	0.21	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.14	9.53	4.48	3.08	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	17.60	12.99	4.79	3.76	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.16	7.84	4.56	3.46	0.55	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	23.55	10.79	4.41	3.56	0.25	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	18.94	11.95	6.18	3.22	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.86	7.31	4.72	2.83	0.24	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	24.60	13.49	3.57	2.78	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	19.88	10.76	6.78	3.98	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	30.07	5.60	4.77	2.90	0.62	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.32	10.18	5.09	4.20	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	29.03	13.16	4.39	3.97	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	24.90	9.29	5.52	2.69	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	23.84	10.73	3.41	2.21	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	23.33	11.37	5.21	2.51	0.39	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	18.57	7.91	7.91	2.06	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	24.69	9.60	3.98	2.47	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.03	11.00	5.09	4.43	0.66	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.90	8.86	5.62	2.22	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.12	8.73	7.10	2.37	0.89	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	17.06	14.39	4.53	2.67	0.00	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.98	12.31	8.85	2.90	0.55	1.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.33	8.57	6.19	2.14	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.94	16.53	6.85	2.62	0.40	1.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	22.70	9.23	6.59	2.54	0.47	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.26	14.32	9.78	3.49	0.35	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	24.78	13.00	10.58	4.84	0.91	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	19.58	9.79	5.14	3.06	0.24	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	20.81	11.50	8.30	4.22	0.44	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	13.99	21.29	7.30	0.61	1.22	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	19.89	9.64	6.63	4.82	0.60	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.83	13.35	7.92	2.49	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	16.18	16.18	7.19	4.79	0.60	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	16.77	7.67	10.39	3.78	0.24	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.91	14.09	5.98	4.70	0.43	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	17.43	21.03	3.61	3.61	0.60	1.20
Schwann Cells, donor1	11498-119F4	58.11	25.01	2.44	0.75	0.75	0.75
Schwann Cells, donor2	11578-120F3	6.80	6.80	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.19	12.49	1.97	0.88	1.10	0.22
Sebocyte, donor1	11220-116B5	29.58	16.98	1.10	1.10	0.55	0.55
Sebocyte, donor2	11301-117B5	25.74	24.82	1.84	0.00	1.84	0.00
Sebocyte, donor3	11378-118B1	23.29	29.27	3.30	1.03	0.41	1.24
Sertoli Cells, donor1	11255-116F4	14.91	8.28	1.66	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	8.47	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	27.10	24.37	5.98	0.44	0.70	0.53
Skeletal Muscle Cells, donor2	11358-117H8	24.58	37.59	8.67	0.00	0.72	2.17
Skeletal Muscle Cells, donor3	11430-118G8	65.21	46.82	7.52	0.84	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	35.19	23.25	3.46	0.94	0.94	0.79
Skeletal Muscle Cells, donor5	11455-119A6	35.23	23.93	1.78	0.74	0.89	1.49
Skeletal Muscle Cells, donor6	11459-119B1	34.94	26.32	1.54	1.08	0.62	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.59	21.30	3.02	0.63	0.38	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.11	25.83	2.71	0.57	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.83	31.45	2.78	1.59	0.99	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	28.65	19.04	3.54	0.76	0.84	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	45.60	41.98	10.13	0.72	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	45.13	23.67	4.82	0.14	0.55	0.83
Skin - palm, donor1	10286-104F7	45.66	8.06	2.69	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	17.30	9.80	1.01	1.30	1.01	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.98	11.45	4.09	1.64	3.27	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	20.51	12.59	1.43	0.52	1.04	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	16.68	8.76	2.64	0.83	1.25	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	16.03	6.47	1.13	0.56	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	41.87	8.88	2.75	3.17	1.90	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	13.12	11.84	1.35	0.60	0.30	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.45	10.18	7.10	0.00	0.31	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.45	2.89	3.33	0.00	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	38.21	24.10	3.53	0.59	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	17.68	7.96	1.10	0.88	1.10	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	32.68	16.93	7.09	1.18	0.39	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.08	20.09	4.64	0.77	3.09	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	11.01	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	26.48	13.17	3.06	0.53	0.27	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.06	14.85	3.55	0.66	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	26.50	16.39	2.56	0.51	0.77	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	20.84	10.74	4.56	0.65	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.99	17.13	5.91	0.59	1.77	2.95
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.38	11.10	1.00	0.85	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	34.98	27.17	6.34	1.63	0.98	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	19.79	14.00	0.61	0.30	0.61	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	46.72	22.23	2.78	0.51	1.52	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	24.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	33.86	13.35	2.38	0.95	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.91	9.14	2.65	0.59	1.18	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.82	14.21	2.58	0.65	1.08	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.25	17.84	3.15	0.63	0.52	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	35.89	18.56	6.19	1.39	2.17	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	24.79	18.32	3.23	4.31	2.16	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.33	14.05	2.39	1.20	0.30	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	39.26	22.87	3.41	2.39	1.37	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.44	17.98	2.51	0.31	0.16	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.80	11.17	6.74	1.71	0.60	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.89	5.69	2.50	1.59	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.79	14.49	3.62	2.42	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	29.41	14.31	2.65	3.44	1.85	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.43	11.05	5.06	0.40	0.67	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	23.54	8.51	3.88	1.13	0.63	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	16.49	2.79	0.25	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.11	11.31	3.92	1.36	0.45	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.76	27.76	3.75	0.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	14.21	0.00	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	39.07	30.23	4.65	0.47	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.69	12.12	2.02	0.50	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.86	10.03	1.88	1.88	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.66	18.29	5.01	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	27.66	17.08	2.08	1.25	0.83	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.03	19.15	3.27	0.47	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.89	18.42	1.58	2.01	0.58	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	32.89	31.61	7.14	2.80	1.27	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	40.62	23.13	3.57	1.32	0.56	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	26.55	13.28	1.96	0.42	1.12	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	19.36	11.65	2.01	0.42	0.75	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	40.00	51.90	15.24	0.48	0.48	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.49	21.29	2.94	1.71	0.49	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	28.06	8.18	1.77	0.66	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	27.21	15.51	1.17	1.17	0.59	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.55	12.05	2.72	0.00	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.75	16.40	6.35	0.26	1.06	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.41	3.72	1.49	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.37	12.94	1.80	0.36	0.36	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.76	14.19	3.41	0.57	1.70	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	20.48	15.36	3.94	1.97	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	12.19	11.94	3.30	0.51	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	7.19	16.77	0.80	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	15.05	20.06	3.34	0.42	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	18.79	20.17	2.75	0.46	0.92	0.92
Synoviocyte, donor1	11291-117A4	10.94	7.74	0.84	0.67	0.34	0.00
Synoviocyte, donor2	11368-117I9	23.80	13.41	2.01	0.84	0.00	0.84
Synoviocyte, donor3	11440-118H9	24.58	11.84	3.13	0.22	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	55.03	30.73	4.29	2.86	1.79	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	55.50	21.80	3.96	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	60.90	26.16	4.40	2.55	2.08	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	29.32	27.89	4.23	0.22	0.93	1.08
Tracheal Epithelial Cells, donor2	11369-118A1	43.68	32.47	3.09	1.55	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	56.69	28.63	5.15	1.15	1.72	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.19	8.86	0.98	0.49	0.25	0.00
Urethra, donor2	10319-105A4	17.98	19.78	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	18.33	16.47	2.66	0.80	0.80	0.80
Urothelial Cells, donor2	11600-120H7	21.23	12.82	2.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	18.79	14.90	2.52	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	16.49	14.49	2.45	0.22	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	16.91	4.45	1.78	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	1.43	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	11.64	4.79	3.42	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.63	3.44	4.13	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	18.59	1.74	1.74	0.58	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	16.66	0.00	2.08	0.00	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	27.53	2.75	5.51	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	14.61	1.83	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	50.08	19.00	4.19	2.84	2.59	0.74
Wilms' tumor cell line:HFWT	10597-108E3	22.88	50.16	4.40	1.76	0.88	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	36.87	18.43	3.35	0.56	0.56	0.84
achilles tendon, donor2	10292-104G4	12.40	8.27	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	47.42	42.32	2.04	0.25	0.51	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	45.97	35.29	5.80	1.16	0.93	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.23	11.87	1.90	0.36	0.24	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	46.26	43.81	19.32	1.63	0.54	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	30.92	48.35	8.43	7.03	1.12	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	34.68	5.08	4.02	3.60	0.85	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	38.38	65.06	32.12	5.72	2.18	4.90
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	15.42	15.42	3.08	0.00	1.76	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	30.22	43.29	14.29	3.68	0.41	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	46.98	39.61	3.88	5.05	1.16	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	42.87	64.58	16.56	3.13	2.21	4.23
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	23.40	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	29.51	16.96	4.42	4.65	1.63	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	54.11	32.88	9.32	4.14	3.11	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	40.04	41.79	4.97	2.34	1.75	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	21.84	13.48	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	21.39	23.85	3.70	1.65	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.89	41.44	2.76	4.91	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	30.30	22.19	3.41	7.68	0.85	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	27.90	24.87	2.43	5.46	1.52	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	21.90	23.83	6.50	5.78	1.20	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	31.63	70.16	8.69	6.90	3.79	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	32.69	21.01	5.34	4.34	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	61.32	7.43	3.72	3.72	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	55.75	32.77	9.42	3.01	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	40.56	32.71	6.98	12.21	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	52.48	33.74	5.62	9.37	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	58.40	38.39	19.55	3.06	0.24	2.12
adipose tissue, adult, pool1	10010-101C1	10.86	7.45	0.16	0.47	0.16	0.00
adipose, donor1	10184-103D4	35.77	11.73	5.86	1.17	1.76	0.00
adipose, donor2	10185-103D5	36.09	28.79	1.22	0.00	0.00	0.41
adipose, donor3	10186-103D6	36.21	21.51	1.63	0.27	1.63	1.09
adipose, donor4	10187-103D7	19.07	37.27	0.00	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	70.23	116.47	7.26	2.53	2.53	4.73
adrenal gland, adult, pool1	10081-102A9	36.38	10.91	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	18.41	11.87	2.40	0.80	0.27	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.59	33.94	6.43	2.50	2.86	0.00
amniotic membrane cells, donor1	12235-129G3	18.78	8.11	3.94	0.46	0.00	0.46
amniotic membrane cells, donor2	12236-129G4	28.74	8.79	2.70	0.68	0.68	0.68
amniotic membrane cells, donor3	12237-129G5	17.68	6.78	5.30	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	45.06	32.02	14.23	0.00	2.37	1.19
amygdala, adult, donor10252	10151-102I7	28.39	27.37	9.12	1.42	2.03	3.04
amygdala, newborn, donor10223	10360-105E9	21.95	13.56	10.97	1.94	1.94	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	21.26	19.74	6.49	0.13	0.25	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	37.95	53.17	11.91	5.07	0.88	2.21
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	51.11	35.74	6.01	0.67	0.00	1.34
aorta, adult, pool1	10052-101G7	16.87	10.59	1.18	0.00	0.20	0.20
appendix, adult	10189-103D9	26.78	8.54	1.16	0.39	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	54.00	38.86	4.13	1.38	2.75	1.38
artery, adult	10190-103E1	25.82	6.79	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	17.82	22.89	4.06	2.17	0.29	1.16
b cell line:RPMI1788	10427-106D4	31.97	17.84	2.83	0.15	0.30	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.98	8.60	1.66	1.39	0.00	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	24.81	6.15	1.98	2.38	1.19	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	37.49	19.25	12.89	1.51	1.84	2.68
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	38.59	38.59	11.74	0.00	0.56	3.36
bladder, adult, pool1	10011-101C2	13.36	5.11	1.63	0.11	0.22	0.11
blood, adult, pool1	10053-101G8	26.58	2.21	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	10.28	3.43	0.86	0.00	0.00
bone marrow, adult	10192-103E3	16.20	10.12	3.37	1.35	0.00	0.67
brain, adult, donor1	10084-102B3	45.10	35.88	11.28	2.05	4.10	2.05
brain, adult, pool1	10012-101C3	34.74	23.83	9.69	1.11	1.67	1.00
brain, fetal, pool1	10085-102B4	56.10	42.74	18.70	0.00	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	56.82	17.84	3.63	5.62	1.32	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	56.42	20.60	9.74	3.37	0.62	0.62
breast, adult, donor1	10080-102A8	8.21	15.15	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	63.77	33.16	16.01	1.14	1.40	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	23.81	19.17	2.47	0.31	0.62	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	12.66	6.45	1.15	0.46	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	29.29	21.55	3.39	0.97	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	41.37	64.88	10.81	0.47	0.47	2.35
carcinoid cell line:NCI-H727	10735-110B6	52.50	38.72	2.30	1.31	0.55	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	50.39	33.59	8.24	0.00	0.32	2.22
carcinosarcoma cell line:JHUCS-1	10642-109A3	46.85	45.78	12.78	2.40	1.86	3.19
caudate nucleus - adult, donor10196	10177-103C6	47.20	25.33	18.42	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	36.48	16.57	15.23	1.84	1.00	2.18
caudate nucleus, adult, donor10258	10379-105H1	60.37	29.04	24.45	0.76	3.06	2.29
caudate nucleus, newborn, donor10223	10354-105E3	25.27	10.62	14.65	0.37	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	87.40	32.05	46.61	8.74	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	39.29	33.09	26.48	1.71	1.71	0.85
cerebellum, adult, pool1	10083-102B2	43.46	22.77	17.59	1.03	0.69	1.38
cerebellum, newborn, donor10223	10357-105E6	16.61	15.78	14.95	0.00	2.49	0.00
cerebral meninges, adult	10188-103D8	31.52	25.21	7.31	1.76	2.27	0.76
cerebrospinal fluid, donor2	10294-104G6	27.04	8.04	1.46	0.00	1.46	1.46
cervical cancer cell line:D98-AH2	10552-107I3	69.45	40.55	12.80	2.59	1.15	1.87
cervical cancer cell line:ME-180	10553-107I4	33.47	3.81	1.33	0.66	0.83	0.17
cervix, adult, pool1	10013-101C4	20.68	5.77	1.26	0.00	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.08	11.15	6.69	1.53	0.42	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	23.51	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	25.23	32.06	1.37	0.37	1.49	0.62
choriocarcinoma cell line:SCH	10785-110H2	50.02	25.38	6.16	1.48	1.85	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	32.26	59.29	3.79	1.19	1.42	1.66
chorionic membrane cells, donor1	12238-129G6	11.40	9.69	3.99	0.00	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	15.51	11.73	1.89	0.80	0.00	0.40
chorionic membrane cells, donor3	12240-129G8	17.03	6.04	1.10	0.00	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	29.28	24.24	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	32.66	24.20	1.34	2.69	2.11	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	35.27	16.68	2.11	3.80	0.63	1.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	39.55	21.83	4.88	1.03	0.77	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	42.81	22.74	4.35	0.48	0.73	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	43.78	21.79	3.26	1.63	0.61	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	62.72	29.74	4.12	1.18	2.94	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.52	17.98	3.13	5.99	0.26	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	31.77	14.40	6.63	2.06	0.69	1.14
clear cell carcinoma cell line:TEN	10636-108I6	21.17	4.86	1.91	0.35	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	38.26	20.32	5.13	0.18	3.29	0.18
colon carcinoma cell line:COLO-320	10420-106C6	72.98	79.44	11.40	0.00	1.90	3.04
colon, adult, donor1	10082-102B1	30.94	24.99	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	27.73	7.76	0.47	0.24	0.12	0.47
colon, fetal, donor1	10070-101I7	19.16	9.89	2.47	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	36.67	22.92	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	50.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	39.52	11.05	3.40	8.07	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	25.05	23.85	6.34	5.89	2.26	1.66
cord blood derived cell line:COBL-a untreated	10449-106F8	27.64	21.01	5.22	6.20	0.99	0.99
corpus callosum, adult, pool1	10042-101F6	43.45	19.13	5.64	1.22	0.44	2.10
cruciate ligament, donor2	10295-104G7	18.64	6.48	0.81	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	33.71	7.22	0.80	0.00	0.80	0.00
diencephalon, adult	10193-103E4	25.68	14.40	7.44	2.88	2.16	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	35.13	39.03	1.84	1.61	0.92	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	32.57	27.18	4.62	1.28	1.80	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.37	29.37	6.74	1.69	1.44	2.65
ductus deferens, adult	10196-103E7	34.39	6.48	2.49	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	8.64	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.16	9.56	0.00	0.00	1.47	0.74
dura mater, adult, donor1	10041-101F5	28.24	10.41	0.58	0.74	0.25	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	87.50	60.40	8.66	7.99	21.99	1.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	54.59	48.00	9.74	2.44	8.88	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	8.02	29.60	3.70	0.62	0.62	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	19.98	13.32	4.54	1.51	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.29	19.45	2.78	2.78	1.85	1.23
embryonic pancreas cell line:2C6	10603-108E9	21.02	21.02	2.63	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.13	19.44	11.40	4.02	2.01	2.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	38.97	21.93	10.87	1.27	1.09	2.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.72	15.60	6.11	2.09	0.96	1.13
epidermoid carcinoma cell line:A431	10426-106D3	25.01	22.23	4.00	1.67	0.78	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	24.53	17.27	2.75	0.88	1.32	0.55
epididymis, adult	10197-103E8	32.23	10.88	1.47	1.26	0.63	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	44.71	15.08	4.79	1.42	0.35	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.46	12.98	9.83	4.33	1.57	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	34.20	19.40	5.90	6.81	1.97	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	46.55	19.39	4.04	6.79	2.36	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	40.11	23.53	6.83	9.30	2.35	1.68
esophagus, adult, pool1	10015-101C6	22.83	8.81	0.85	0.21	0.21	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	50.72	22.92	32.31	0.63	0.88	2.63
eye - muscle inferior rectus, donor1	10272-104E2	7.24	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	18.94	0.00	6.31	2.10	0.00
eye - muscle medial, donor2	10299-104H2	7.44	8.93	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	25.22	9.17	1.15	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	8.74	0.00	1.46	1.46	0.00
eye, fetal, donor1	10054-101G9	33.81	16.78	5.34	0.25	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	31.54	18.85	3.46	1.03	0.90	1.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.99	20.89	9.50	2.37	1.19	0.71
frontal lobe, adult, pool1	10040-101F4	36.40	25.71	14.54	1.31	1.88	1.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	34.53	12.01	4.80	5.10	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	20.66	16.64	4.75	0.73	0.37	0.46
gall bladder, adult	10198-103E9	20.52	8.21	0.97	0.24	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	30.06	8.59	4.29	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	28.39	4.11	4.11	1.12	1.12	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.70	5.49	3.80	0.63	0.42	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	12.57	16.63	2.51	0.39	0.58	0.97
gastric cancer cell line:AZ521	10549-107H9	54.92	74.11	16.23	3.28	1.97	4.10
gastric cancer cell line:GSS	10560-108A2	43.93	51.25	15.56	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.10	17.59	11.42	1.83	0.46	1.37
giant cell carcinoma cell line:LU65	10487-107B1	8.26	13.54	0.46	0.34	0.34	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	27.99	12.88	3.36	0.56	0.14	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.43	17.71	2.49	3.49	1.00	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	29.13	18.47	3.80	1.06	0.95	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	35.81	17.41	6.04	0.98	0.70	0.42
glioblastoma cell line:T98G	10485-107A8	24.72	35.32	3.86	0.88	0.22	0.99
glioma cell line:GI-1	10413-106B8	29.29	21.67	12.30	0.29	0.59	1.76
globus pallidus - adult, donor10196	10175-103C4	38.63	16.04	8.75	1.46	2.92	0.73
globus pallidus, adult, donor10252	10161-103A8	22.46	26.85	4.88	1.95	0.73	1.22
globus pallidus, adult, donor10258	10367-105F7	31.49	8.22	6.85	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	22.38	13.86	6.40	2.13	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	17.13	34.26	0.00	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	26.13	0.00	5.23	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	20.16	13.12	0.96	0.96	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	31.22	54.63	3.67	0.46	0.46	0.92
hIPS +CCl2, biol_rep2	14384-156C1	26.52	48.93	2.74	0.91	1.83	0.46
hIPS +CCl2, biol_rep3	14385-156C2	38.00	59.26	3.86	0.64	3.86	0.64
hIPS, biol_rep1	14380-156B6	21.56	64.68	2.87	0.00	2.87	0.00
hIPS, biol_rep2	14381-156B7	28.12	41.84	1.37	2.06	5.49	0.00
hIPS, biol_rep3	14382-156B8	39.72	23.17	18.76	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	29.02	25.29	3.16	7.47	0.57	1.15
heart - mitral valve, adult	10205-103F7	16.14	10.46	0.90	0.30	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	16.47	8.11	0.78	1.31	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	16.65	3.33	1.67	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	33.26	10.61	2.45	1.63	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	31.09	8.52	1.28	2.98	0.43	0.00
heart, adult, pool1	10016-101C7	25.99	14.49	0.46	2.07	0.23	0.00
heart, fetal, pool1	10046-101G1	32.45	21.97	0.92	1.03	0.41	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.97	7.10	0.93	0.31	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	22.59	29.73	0.00	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	32.93	20.77	4.97	5.41	2.21	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	30.83	21.73	7.28	5.95	2.06	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.65	20.61	4.85	5.96	2.02	0.81
hepatoma cell line:Li-7	10484-107A7	25.80	5.23	2.45	5.67	0.89	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	39.50	70.75	9.25	2.91	1.61	2.41
hippocampus - adult, donor10196	10169-103B7	38.80	34.07	10.41	0.00	6.62	2.84
hippocampus, adult, donor10252	10153-102I9	25.31	26.74	8.57	1.02	2.25	1.22
hippocampus, adult, donor10258	10374-105G5	37.35	29.88	12.45	1.00	3.49	0.50
hippocampus, newborn, donor10223	10363-105F3	23.26	21.50	9.87	1.06	2.11	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	40.89	61.03	3.05	0.00	3.66	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.22	58.71	0.98	0.79	1.96	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.38	63.73	1.52	0.76	1.52	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	60.90	45.67	2.26	1.13	2.82	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	65.33	48.54	2.84	0.00	1.81	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	63.39	50.11	1.90	0.76	2.28	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	46.42	25.98	2.63	0.00	0.88	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	46.10	26.28	1.72	0.43	1.94	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	49.63	30.86	1.25	0.00	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	50.44	24.86	3.55	0.47	0.95	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	55.45	27.32	2.41	0.96	1.77	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.19	15.49	2.69	3.37	2.69	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	29.89	53.20	0.31	0.94	4.07	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	40.78	57.48	1.47	0.49	1.97	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	30.55	23.56	0.00	3.49	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	65.10	31.50	1.34	1.15	2.29	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	56.69	36.19	0.87	0.44	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	47.48	25.49	1.00	0.50	3.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	35.04	17.90	1.70	0.19	0.75	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	51.38	21.83	2.73	0.00	1.36	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.21	18.48	2.19	0.00	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	32.50	15.19	2.61	0.98	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.90	17.42	1.74	0.00	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	40.95	15.54	3.89	0.60	0.90	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	34.73	53.95	1.29	0.55	1.11	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	39.37	61.62	1.43	0.00	0.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	41.24	55.12	0.82	1.22	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	46.83	42.95	1.41	0.70	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	46.24	38.33	3.80	0.00	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	48.72	38.74	3.33	0.91	2.72	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	43.44	24.30	3.10	0.00	2.07	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	31.22	24.57	3.32	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.02	26.42	3.85	0.26	1.03	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	39.88	23.01	3.83	1.79	1.28	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	59.06	22.72	2.27	2.27	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	33.94	18.82	1.34	0.67	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	42.75	64.48	1.69	0.72	0.97	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	41.45	65.51	1.78	1.78	1.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	37.56	54.63	2.93	1.46	2.93	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	59.29	34.53	0.31	0.31	2.14	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	3.25	6.51	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	54.94	22.84	1.65	0.33	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	61.84	26.82	1.09	0.55	1.64	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	49.22	25.33	2.17	0.36	2.53	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	47.69	19.93	1.78	0.00	2.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	39.38	25.06	5.97	0.00	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	45.64	29.12	2.84	0.95	1.49	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	35.02	29.09	4.31	0.54	0.54	0.27
immature langerhans cells, donor1	11904-125F5	18.40	2.42	0.24	0.48	1.21	0.00
immature langerhans cells, donor2	11905-125F6	14.26	2.38	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	44.19	35.58	19.02	1.14	2.18	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	36.42	26.66	4.23	0.33	0.00	0.98
kidney, adult, pool1	10017-101C8	25.53	13.92	1.60	1.60	1.10	0.50
kidney, fetal, pool1	10045-101F9	36.57	11.67	2.26	1.27	0.64	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	27.55	7.95	3.98	2.56	0.71	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	26.40	40.92	4.01	0.55	0.83	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.83	8.62	0.73	0.55	0.18	0.18
left atrium, adult, donor1	10079-102A7	17.44	16.35	0.00	1.09	0.00	0.54
left ventricle, adult, donor1	10078-102A6	17.19	15.17	0.51	2.02	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	41.86	66.76	6.84	4.38	1.92	3.28
leiomyoma cell line:10964C	10569-108B2	8.62	10.42	3.23	1.08	0.72	0.36
leiomyoma cell line:15242A	10570-108B3	6.52	7.61	1.63	1.09	1.63	0.00
leiomyoma cell line:15425	10571-108B4	13.84	8.26	2.91	0.49	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	12.70	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	6.27	2.09	4.18	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	37.42	49.23	6.14	4.25	0.83	2.36
liposarcoma cell line:KMLS-1	10782-110G8	62.17	28.90	8.12	2.19	1.56	0.78
liposarcoma cell line:SW 872	10726-110A6	40.09	19.01	4.39	2.19	1.10	0.61
liver, adult, pool1	10018-101C9	22.36	16.37	1.62	2.43	0.16	0.49
liver, fetal, pool1	10086-102B5	17.87	10.35	0.00	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.81	18.67	9.04	3.50	2.19	1.17
locus coeruleus, adult, donor10252	10165-103B3	19.01	19.38	7.20	3.32	1.29	1.66
locus coeruleus, adult, donor10258	10375-105G6	32.16	15.80	15.52	1.97	1.13	3.10
locus coeruleus, newborn, donor10223	10362-105F2	18.93	3.36	15.14	3.36	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	27.96	34.05	8.44	2.21	2.08	2.91
lung adenocarcinoma cell line:PC-14	10408-106B3	54.46	29.64	8.27	2.07	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	20.96	12.39	4.35	2.11	0.53	0.40
lung, adult, pool1	10019-101D1	16.77	7.56	0.71	0.35	0.24	0.12
lung, fetal, donor1	10068-101I5	30.82	4.28	1.43	0.57	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	18.79	3.67	0.92	0.00	0.46	0.00
lymph node, adult, donor1	10077-102A5	16.09	13.73	2.37	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	40.77	28.49	3.07	0.00	0.22	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	38.79	23.24	1.66	1.51	2.11	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	3.40	2.55	1.70	0.85	0.00
mature adipocyte, donor1	12231-129F8	13.76	8.44	0.89	0.44	0.00	0.44
mature adipocyte, donor2	12232-129F9	14.32	11.83	0.00	0.21	0.00	0.21
mature adipocyte, donor3	12233-129G1	19.20	7.11	0.00	0.95	0.24	0.24
mature adipocyte, donor4	12234-129G2	17.90	8.69	0.53	0.53	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	56.23	38.12	6.43	1.67	1.19	1.67
medial frontal gyrus - adult, donor10196	10170-103B8	45.12	38.35	20.30	0.00	2.26	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	33.29	33.10	9.01	2.21	2.94	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	61.63	38.76	20.01	1.91	6.04	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	13.65	8.53	15.35	0.43	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	47.08	38.14	17.04	1.35	2.87	2.03
medial temporal gyrus, adult, donor10252	10156-103A3	36.71	32.05	10.82	2.76	1.27	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	15.41	7.71	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	26.20	27.28	15.43	0.36	1.79	1.44
medulla oblongata - adult, donor10196	10174-103C3	33.75	12.98	4.54	0.65	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	18.27	18.42	6.97	1.70	0.77	0.62
medulla oblongata, adult, pool1	10038-101F2	30.28	15.59	8.08	2.86	1.22	1.31
medulla oblongata, newborn, donor10223	10361-105F1	19.79	18.05	4.17	1.04	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	60.89	31.88	6.42	0.66	2.21	0.66
medulloblastoma cell line:ONS-76	10759-110E3	27.27	18.10	7.46	2.45	0.49	2.32
melanoma cell line:COLO 679	10514-107E1	31.91	11.64	5.75	1.44	1.15	1.15
melanoma cell line:G-361	10465-106H6	18.46	15.47	5.70	0.00	0.54	1.63
meningioma cell line:HKBMM	10691-109F7	15.92	11.58	3.08	1.63	0.36	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	89.00	40.53	12.34	0.88	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	80.36	27.48	7.26	0.26	1.81	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	28.85	16.11	3.53	0.15	0.92	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	19.27	23.27	8.18	0.73	0.36	2.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	22.36	22.36	3.31	0.41	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.06	15.31	2.67	0.42	0.00	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.79	22.53	5.97	1.35	0.58	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	19.43	13.19	7.63	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.98	15.79	3.43	1.72	0.17	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.56	15.53	5.64	0.92	0.35	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.42	12.34	2.39	0.40	0.40	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.96	10.40	1.35	1.22	0.54	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.94	9.96	0.85	0.43	0.14	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.44	19.43	1.98	0.99	0.00	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.99	9.27	1.38	0.55	0.69	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	17.11	10.47	1.40	0.70	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.05	10.62	0.61	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	13.30	11.86	2.16	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.31	11.38	2.28	0.52	0.21	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.94	8.89	0.23	0.46	0.23	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	7.13	3.78	2.10	0.00	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	12.40	10.46	2.84	0.30	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.12	11.20	3.94	0.26	0.96	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.04	20.62	3.31	0.00	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.31	14.02	1.43	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.05	8.84	1.68	4.63	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.38	17.81	3.65	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.07	13.56	3.33	0.51	1.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.70	14.66	2.62	0.52	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	22.80	12.32	3.39	0.31	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.01	16.24	2.59	0.71	0.24	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	20.98	13.20	3.72	0.34	0.34	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.15	9.43	2.75	0.39	1.96	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.07	12.05	3.71	0.46	0.93	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	23.65	17.02	2.60	0.29	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.09	16.06	3.12	0.89	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	26.68	13.22	2.88	0.72	1.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	16.87	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.82	14.43	2.35	0.34	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	13.51	4.09	0.41	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	22.77	16.32	2.58	0.00	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	21.88	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	20.66	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	22.41	13.32	3.25	0.65	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	29.10	13.09	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	32.52	20.79	1.60	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.08	22.90	4.09	0.82	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	23.71	13.61	2.33	0.00	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	14.69	0.00	4.20	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	14.90	4.97	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	23.84	0.00	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.86	15.42	3.56	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	14.62	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.34	15.83	4.43	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	19.31	18.28	3.10	0.00	0.34	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	19.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	19.96	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	17.22	3.44	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.34	20.78	1.22	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	24.63	3.18	0.00	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	24.17	2.95	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.96	23.69	1.87	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	25.40	2.67	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	28.38	35.48	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	53.93	7.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	36.49	4.82	2.07	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	42.06	20.29	1.48	1.98	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	44.86	21.31	0.00	2.24	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.17	22.26	1.27	0.64	1.91	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	66.90	43.52	2.82	3.63	2.42	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	43.61	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	57.02	31.68	5.07	0.00	5.07	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	30.34	69.19	5.46	2.43	1.82	5.46
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	81.34	18.08	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	52.72	68.37	4.94	2.47	2.47	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.82	20.24	1.59	0.20	0.60	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	26.28	19.15	1.30	0.65	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	20.37	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	19.34	2.32	2.32	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.71	30.24	8.50	2.13	0.47	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	16.91	17.38	3.71	2.78	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.88	6.06	6.06	3.08	1.34	0.62
mesothelioma cell line:Mero-25	10850-111F4	39.04	29.50	10.67	13.39	2.95	1.36
mesothelioma cell line:Mero-41	10851-111F5	35.20	23.71	6.60	2.93	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	15.50	10.19	3.99	2.21	1.11	0.66
mesothelioma cell line:Mero-82	10853-111F7	30.75	11.04	9.72	1.31	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	17.53	5.62	3.23	3.23	1.36	0.17
mesothelioma cell line:Mero-84	10855-111F9	32.61	6.82	2.53	3.79	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	33.95	13.04	7.04	1.66	0.41	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	23.19	18.06	4.47	1.49	1.33	0.83
mesothelioma cell line:NCI-H226	10846-111E9	22.44	9.05	6.88	4.34	1.45	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	29.72	18.28	12.64	0.85	0.17	1.37
mesothelioma cell line:NCI-H28	10845-111E8	16.54	19.34	5.34	3.05	1.78	0.51
mesothelioma cell line:No36	10857-111G2	30.99	21.53	11.42	3.91	2.28	0.33
mesothelioma cell line:ONE58	10858-111G3	18.15	9.48	2.98	2.71	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	19.19	0.00	0.58	0.19	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	20.76	1.34	0.12	0.12	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	17.41	4.31	1.08	0.36	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.67	13.06	2.94	1.96	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.90	10.81	4.24	0.64	0.42	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	32.48	24.19	3.92	2.30	0.23	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.97	11.23	0.19	2.28	0.38	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	44.53	47.68	9.61	1.29	1.11	2.77
myeloma cell line:PCM6	10474-106I6	49.42	11.66	9.49	0.40	0.40	2.17
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.89	7.10	1.01	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.63	12.36	7.26	0.00	0.00	2.94
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.48	29.42	3.79	0.11	0.89	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.21	26.18	4.27	0.22	0.29	0.96
nasal epithelial cells, donor2	12227-129F4	26.50	14.35	2.76	0.00	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	73.16	53.37	7.82	0.69	2.30	2.30
neuroblastoma cell line:NB-1	10539-107G8	72.78	23.01	7.86	4.30	2.81	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	41.97	47.87	22.78	0.00	0.42	5.48
neuroblastoma cell line:NH-12	10555-107I6	58.33	46.22	7.64	0.00	1.49	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	38.19	24.20	10.44	0.24	0.00	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	51.00	21.54	6.81	0.00	1.27	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	56.35	28.78	11.47	0.20	1.81	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	82.65	61.03	12.08	0.64	1.27	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	19.96	13.57	1.60	0.53	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	44.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	26.89	8.79	1.18	0.51	0.17	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	14.41	19.21	4.80	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	30.46	9.94	3.21	0.96	0.96	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.71	5.78	1.84	1.05	1.05	0.53
nucleus accumbens, adult, pool1	10037-101F1	43.78	26.34	13.97	1.50	1.22	1.22
occipital cortex - adult, donor10196	10172-103C1	63.87	37.09	16.48	2.06	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	33.28	33.55	11.00	1.34	1.88	1.88
occipital cortex, newborn, donor10223	10355-105E4	27.66	34.21	10.92	1.09	3.28	0.36
occipital lobe, adult, donor1	10076-102A4	45.13	32.01	13.91	1.57	2.89	1.31
occipital lobe, fetal, donor1	10073-102A1	44.63	33.04	11.59	0.86	2.57	1.29
occipital pole, adult, pool1	10036-101E9	58.74	31.85	17.66	1.02	2.76	2.29
olfactory region, adult	10195-103E6	32.10	21.40	8.41	0.57	2.29	1.91
optic nerve, donor1	10277-104E7	34.02	14.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	24.26	27.45	12.64	2.28	0.80	2.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	19.10	29.26	8.93	0.14	0.41	1.65
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	17.44	7.79	2.37	0.17	0.68	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.06	11.44	2.43	1.04	0.69	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	17.34	9.70	0.29	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	46.72	71.01	2.80	3.74	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	26.72	28.63	17.81	2.76	1.91	3.61
ovary, adult, pool1	10020-101D2	23.76	8.91	2.62	0.44	0.35	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	23.47	8.07	3.67	0.55	0.18	0.18
pancreas, adult, donor1	10049-101G4	48.91	17.87	0.00	1.88	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	30.47	29.91	1.12	2.52	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	27.09	10.56	2.73	1.36	1.19	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	22.52	9.44	1.32	0.33	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	42.92	27.37	15.01	1.56	3.29	2.20
parietal cortex, adult, donor10258	10373-105G4	44.04	21.29	14.68	0.73	2.94	1.47
parietal lobe - adult, donor10196	10171-103B9	47.02	35.74	10.35	1.88	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	30.50	33.06	9.69	2.00	1.71	0.86
parietal lobe, adult, pool1	10034-101E7	42.03	29.52	17.71	2.03	2.03	1.59
parietal lobe, fetal, donor1	10072-101I9	26.19	30.06	8.73	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	20.94	23.18	14.21	0.37	2.62	0.37
parotid gland, adult	10199-103F1	30.83	12.95	3.08	0.00	0.00	0.00
penis, adult	10200-103F2	20.95	4.83	1.07	1.07	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	41.46	18.97	8.92	0.00	1.12	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.46	16.61	2.77	0.58	1.17	0.87
pineal gland - adult, donor10196	10179-103C8	42.57	12.90	5.16	3.87	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	47.97	18.36	9.48	1.78	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	63.96	9.41	13.80	3.14	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	30.35	9.11	7.08	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	20.85	17.20	8.34	3.13	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	34.90	11.07	11.07	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	28.70	4.95	0.32	1.29	0.00	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	30.59	20.39	2.38	1.19	0.79	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.81	16.19	4.67	0.47	0.16	0.31
pons, adult, pool1	10033-101E6	26.16	8.43	13.00	6.02	2.24	1.38
postcentral gyrus, adult, pool1	10032-101E5	48.82	33.91	17.87	1.92	3.23	1.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	37.65	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	16.52	16.52	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	35.21	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	19.66	14.86	3.20	1.89	0.87	0.29
prostate cancer cell line:PC-3	10439-106E7	24.50	33.58	11.25	1.63	0.54	1.45
prostate, adult, pool1	10022-101D4	18.59	6.89	2.18	0.36	0.36	0.27
putamen, adult, donor10196	10176-103C5	39.42	18.65	12.75	2.36	1.89	1.18
putamen, adult, donor10252	10152-102I8	29.41	11.76	11.76	0.00	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	21.86	26.23	12.02	0.00	7.65	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	48.56	23.68	18.12	1.69	0.97	0.72
putamen, newborn, donor10223	10365-105F5	17.24	4.50	26.99	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	25.02	14.55	7.56	0.58	0.29	1.16
rectum, fetal, donor1	10067-101I4	34.77	13.91	0.00	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	26.08	14.63	6.15	0.42	0.64	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	16.15	15.33	9.53	0.00	0.00	0.83
retina, adult, pool1	10030-101E3	49.70	13.62	5.77	1.39	0.70	0.50
retinoblastoma cell line:Y79	10475-106I7	51.70	42.61	2.86	0.00	1.56	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	30.86	17.09	4.55	1.11	1.23	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	62.99	41.90	9.00	0.28	1.41	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	27.28	18.95	0.00	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	18.61	22.66	9.06	0.65	0.49	2.10
salivary acinar cells, donor2	11772-123I8	22.31	19.41	3.86	0.00	0.41	0.69
salivary acinar cells, donor3	11773-123I9	27.81	27.81	1.32	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	47.47	15.44	3.43	1.14	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.05	21.50	15.09	1.01	0.59	1.18
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	30.21	23.51	15.63	1.18	0.47	2.94
seminal vesicle, adult	10201-103F3	23.81	5.29	4.76	0.53	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.71	5.83	1.46	1.21	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.67	20.89	3.77	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	26.09	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	34.52	10.34	11.15	2.96	1.07	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	40.56	10.83	4.64	1.33	1.33	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	36.13	18.32	7.48	1.68	1.68	1.42
skeletal muscle - soleus muscle, donor1	10282-104F3	51.07	8.51	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	44.26	7.56	0.24	0.84	0.84	0.00
skeletal muscle, fetal, donor1	10066-101I3	54.27	24.12	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	20.36	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	28.41	14.52	1.26	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	49.36	36.69	5.00	1.67	1.33	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	38.46	26.48	19.54	1.26	2.52	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	53.78	63.03	9.83	0.19	0.39	6.55
small cell lung carcinoma cell line:LK-2	10541-107H1	53.73	32.80	7.58	0.00	1.32	2.14
small cell lung carcinoma cell line:NCI-H82	10842-111E5	61.61	40.05	2.90	0.00	1.45	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	46.42	22.01	13.29	8.93	2.83	2.18
small intestine, adult, pool1	10024-101D6	30.22	8.84	0.96	0.36	0.48	0.12
small intestine, fetal, donor1	10064-101I1	36.36	8.11	0.49	0.00	0.00	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	27.70	28.21	7.69	2.05	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	16.28	8.27	0.52	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	43.96	50.12	3.22	0.54	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	24.55	13.99	4.59	0.46	1.38	0.23
spinal cord, adult, donor10252	10159-103A6	12.62	26.81	4.34	0.79	0.00	1.58
spinal cord, adult, donor10258	10369-105F9	29.06	9.69	8.99	2.08	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	34.15	25.61	6.71	0.61	1.22	1.83
spinal cord, newborn, donor10223	10359-105E8	16.53	6.89	5.51	0.46	1.84	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.49	9.41	1.34	0.90	0.30	0.30
spleen, adult, pool1	10025-101D7	17.73	8.48	1.10	1.32	0.66	0.11
spleen, fetal, pool1	10044-101F8	24.23	7.23	1.67	1.43	0.16	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	32.40	11.90	4.04	0.31	1.04	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.30	9.11	5.89	0.57	0.57	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.66	11.18	3.49	3.84	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	32.06	12.51	1.95	1.95	1.17	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	61.79	14.97	6.98	2.03	1.58	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	20.33	34.74	9.32	0.00	2.12	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	15.65	21.15	3.81	2.12	2.12	0.85
stomach, fetal, donor1	10062-101H8	33.11	4.27	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	29.05	9.68	2.28	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.49	18.07	5.61	1.04	0.00	1.04
substantia nigra, adult, donor10258	10371-105G2	33.62	20.69	18.62	5.17	5.17	1.03
substantia nigra, newborn, donor10223	10358-105E7	16.96	17.66	2.12	1.41	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	50.67	36.45	13.76	0.00	2.75	4.59
temporal lobe, adult, pool1	10031-101E4	47.05	35.01	16.11	1.53	2.46	1.95
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.17	27.07	14.25	1.42	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	25.93	14.07	10.55	0.00	0.88	1.32
tenocyte, donor1	11763-123H8	20.25	17.80	2.09	1.40	0.35	1.05
tenocyte, donor2	11765-123I1	19.84	14.88	1.14	1.14	0.38	0.38
tenocyte, donor3	11768-123I4	16.68	12.23	2.59	1.11	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	28.55	46.74	0.17	0.85	2.04	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	45.78	14.64	3.39	0.77	1.54	0.77
teratocarcinoma cell line:PA-1	10807-111A6	48.66	66.02	1.24	0.62	1.55	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	39.48	48.37	1.27	4.57	1.78	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	35.93	63.53	5.29	3.03	1.51	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.09	38.28	2.07	3.27	0.65	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.52	18.57	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	74.19	11.17	2.04	0.54	4.19	0.86
testis, adult, pool2	10096-102C6	103.75	14.89	4.51	0.90	8.12	1.35
thalamus - adult, donor10196	10168-103B6	36.43	16.56	8.83	5.52	0.00	1.10
thalamus, adult, donor10252	10154-103A1	27.82	19.85	7.35	1.25	0.47	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	15.40	21.55	6.16	10.78	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	33.76	14.82	7.91	5.11	2.96	1.15
thalamus, newborn, donor10223	10366-105F6	13.23	4.60	10.36	6.33	2.88	1.15
throat, adult	10209-103G2	27.21	5.24	0.50	0.75	0.00	0.00
throat, fetal, donor1	10061-101H7	42.66	8.84	1.52	0.61	0.91	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	51.87	49.68	21.26	0.00	1.59	1.99
thymus, adult, pool1	10027-101D9	35.69	7.26	2.09	0.50	0.30	0.40
thymus, fetal, pool1	10043-101F7	30.86	4.88	1.66	0.31	0.42	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	30.45	12.37	3.99	0.93	0.93	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	47.22	23.19	10.20	0.98	0.14	1.96
thyroid, adult, pool1	10028-101E1	43.30	10.36	4.01	0.65	0.65	0.56
thyroid, fetal, donor1	10060-101H6	40.08	7.65	2.64	0.53	0.53	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	27.21	8.84	0.93	0.70	1.16	0.47
tongue, fetal, donor1	10059-101H5	36.26	12.22	0.00	0.79	0.39	0.79
tonsil, adult, pool1	10047-101G2	35.06	9.12	2.20	0.40	0.60	0.20
trachea, adult, pool1	10029-101E2	23.07	7.36	1.96	0.82	0.08	0.16
trachea, fetal, donor1	10058-101H4	25.77	10.00	1.15	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.80	11.69	3.54	1.77	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	24.72	18.03	4.05	0.41	1.32	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	38.70	33.84	7.52	4.54	0.47	1.57
tridermal teratoma cell line:HGRT	10694-109G1	41.86	20.93	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.42	19.05	3.72	1.35	0.93	0.85
umbilical cord, fetal, donor1	10057-101H3	12.52	8.35	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	32.42	4.78	2.05	0.34	0.34	0.00
uterus, fetal, donor1	10055-101H1	40.44	12.80	0.51	0.51	0.51	0.51
vagina, adult	10204-103F6	10.34	9.69	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	18.41	7.67	0.88	1.10	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	24.83	12.82	3.20	0.00	0.27	1.07

Property "Nearest transcripts" (as page type) with input value "ENST00000301724.14:-216 BC020499:-216 ENST00000563067.5:218 BC017119:218 ENST00000565717.5:-220 ENST00000567282.5:-223 BC001313:-223 ENST00000564679.5:-226 ENST00000561651.5:-229 ENST00000565687.5:-229 ENST00000566653.5:-233 ENST00000568194.5:-239 BC052292:-239 BC088354:-243 ENST00000563107.5:-245 ENST00000565269.1:-253 ENST00000567928.5:-254 ENST00000562479.5:-254 ENST00000562844.5:-254 ENST00000562851.5:-256 ENST00000567623.6:-256 ENST00000562352.5:-256 ENST00000565330.5:-256 ENST00000569417.6:-256 NM_001199173.3:-256 NM_001352060.2:-256 NM_001199175.3:-256 NM_022372.6:-256 NM_001352057.2:-256 NM_001352059.2:-256 NM_001199174.3:-256 NR_147904.2:-256 NR_147906.2:-256 NR_147905.2:-256 NR_147907.2:-256 AK302201:-256 ENST00000564294.5:-260 AK304390:-260 LF210723:-262 MA446300:-262 DQ894803:263 EU176591:263 DQ891611:263 CU677841:274 AY223837:-287 ENST00000568542.5:-453 AK098762:-468 ENST00000570224.5:-485" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.